Our “Antibody Discovery & Development“ series is designed to inform and educate our members and the broader scientific community about scientific advances relating to the discovery and development of antibody therapeutics.
Our “Commercializing Antibody Therapeutics“ series provides guidance on how to progress antibody therapeutics from preclinical study to the market.
Our “Adaptive Immune Receptor Repertoires “ series is designed to inform and educate our members (particularly AIRR Community Members) and the broader scientific community about scientific advances relating to the use of next-generation sequencing technologies to study antibody/B-cell and T-cell receptor repertoires, computational systems immunology and related areas. Other recorded talks about AIRR studies can be found on the AIRR Community YouTube Channel.
Webinars in the “Antibodies to Watch“ series provide timely updates on events related to antibody therapeutics in late-stage development and regulatory review, and those that were recently approved.
The On Demand webinars in our “Antibody Validation“ series” (Webinars #1-10) are aimed especially at those beginning a career in biological sciences. In this series hosted by Dr. Simon Goodman, leaders in antibody research from industry and academia reflect on antibody validation.